|
FR2773482B1
(fr)
†
|
1998-01-13 |
2001-04-20 |
Oreal |
Composition de teinture d'oxydation des fibres keratiniques et procede de teinture mettant en oeuvre cette composition
|
|
DE10238722A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
|
|
DE10238724A1
(de)
|
2002-08-23 |
2004-03-04 |
Bayer Ag |
Alkyl-substituierte Pyrazolpyrimidine
|
|
DE10238723A1
(de)
|
2002-08-23 |
2004-03-11 |
Bayer Ag |
Phenyl-substituierte Pyrazolyprimidine
|
|
MXPA05007485A
(es)
|
2003-01-14 |
2006-01-30 |
Arena Pharm Inc |
Derivados de arilo y heteroarilo 1,2,3-trisubstituidos como moduladores del metabolismo y la profilaxis y tratamiento de trastornos relacionados con ello tales como diabetes e hiperglicemia.
|
|
CA2524900C
(en)
*
|
2003-05-09 |
2012-03-20 |
Bayer Healthcare Ag |
6-cyclylmethyl- and 6-alkylmethyl-substituted pyrazolopyrimidines
|
|
DE102004004142A1
(de)
*
|
2003-05-09 |
2004-11-25 |
Bayer Healthcare Ag |
6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine
|
|
US8044060B2
(en)
|
2003-05-09 |
2011-10-25 |
Boehringer Ingelheim International Gmbh |
6-cyclylmethyl- and 6-alkylmethyl pyrazolo[3,4-D]pyrimidines, methods for their preparation and methods for their use to treat impairments of perception, concentration learning and/or memory
|
|
DE10320785A1
(de)
|
2003-05-09 |
2004-11-25 |
Bayer Healthcare Ag |
6-Arylmethyl-substituierte Pyrazolopyrimidine
|
|
DE10328479A1
(de)
|
2003-06-25 |
2005-01-13 |
Bayer Ag |
6-Arylamino-5-cyano-4-pyrimidinone
|
|
DE102004001873A1
(de)
|
2004-01-14 |
2005-09-29 |
Bayer Healthcare Ag |
Cyanopyrimidinone
|
|
DOP2006000009A
(es)
*
|
2005-01-13 |
2006-08-15 |
Arena Pharm Inc |
Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
|
|
WO2006134459A1
(en)
*
|
2005-06-15 |
2006-12-21 |
Pfizer Limited |
Substituted arylpyrazoles
|
|
US8097712B2
(en)
|
2007-11-07 |
2012-01-17 |
Beelogics Inc. |
Compositions for conferring tolerance to viral disease in social insects, and the use thereof
|
|
JP5498392B2
(ja)
*
|
2007-11-30 |
2014-05-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
1,5−ジヒドロ−ピラゾロ[3,4−d]ピリミジン−4−オン誘導体及びcns障害の治療のためのpde9aモジュレーターとしてのそれらの使用
|
|
UA105362C2
(en)
*
|
2008-04-02 |
2014-05-12 |
Бьорингер Ингельхайм Интернациональ Гмбх |
1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
|
|
JP5453431B2
(ja)
|
2008-09-08 |
2014-03-26 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ピラゾロピリミジン及びcns障害の治療のためのそれらの使用
|
|
PE20120505A1
(es)
|
2009-03-31 |
2012-05-09 |
Boehringer Ingelheim Int |
Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona como moduladores de pde9a
|
|
AR077859A1
(es)
*
|
2009-08-12 |
2011-09-28 |
Boehringer Ingelheim Int |
Compuestos para el tratamiento de trastornos del snc
|
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
|
SG10201906876PA
(en)
|
2010-01-27 |
2019-09-27 |
Arena Pharm Inc |
Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
|
|
ES2641642T3
(es)
|
2010-03-08 |
2017-11-10 |
Monsanto Technology Llc |
Moléculas de polinucleótido para regulación génica en plantas
|
|
AP2012006631A0
(en)
|
2010-08-12 |
2012-12-31 |
Boehringer Ingelheim Int |
6-Cycloalkyl-1, 5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivatives and their use as PDE9A inhibitors
|
|
PH12013500547A1
(en)
|
2010-09-22 |
2013-06-10 |
Arena Pharm Inc |
Modulators of the gpr119 receptor and the treatment of disorders related thereto
|
|
US8809345B2
(en)
|
2011-02-15 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
|
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
|
CN103930549B
(zh)
|
2011-09-13 |
2020-09-18 |
孟山都技术公司 |
用于杂草控制的方法和组合物
|
|
EP2756085B1
(en)
|
2011-09-13 |
2019-03-20 |
Monsanto Technology LLC |
Methods and compositions for weed control
|
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
|
MX361938B
(es)
|
2011-09-13 |
2018-12-19 |
Monsanto Technology Llc |
Métodos y composiciones para el control de malezas.
|
|
EP3382027A3
(en)
|
2011-09-13 |
2018-10-31 |
Monsanto Technology LLC |
Methods and compositions for weed control
|
|
CA2848695A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and composition for weed control comprising inhibiting ppg oxidase
|
|
WO2013040057A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
|
MX348495B
(es)
|
2011-09-13 |
2017-06-14 |
Monsanto Technology Llc |
Metodos y composiciones para el control de malezas.
|
|
MX360866B
(es)
|
2012-05-24 |
2018-11-09 |
A B Seeds Ltd |
Composiciones y métodos para silenciar la expresión genética.
|
|
UY35252A
(es)
|
2013-01-01 |
2014-07-31 |
Seeds Ltd Ab |
MÉTODOS PARA INTRODUCIR dsRNA EN SEMILLAS DE PLANTAS PARA MODULAR LA EXPRESIÓN GENÉTICA
|
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
|
AU2014224784B2
(en)
*
|
2013-03-07 |
2018-03-08 |
F. Hoffmann-La Roche Ag |
Novel pyrazol derivatives
|
|
US10612019B2
(en)
|
2013-03-13 |
2020-04-07 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
|
BR112015023051A2
(pt)
|
2013-03-13 |
2017-11-14 |
Monsanto Technology Llc |
método para controle de ervas daninhas, composição herbicida, cassete de expressão microbiano e método de produção de polinucleotídeo
|
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
|
AU2014261585B2
(en)
|
2013-05-02 |
2018-03-08 |
F. Hoffmann-La Roche Ag |
Purine derivatives as CB2 receptor agonists
|
|
WO2014177527A1
(en)
|
2013-05-02 |
2014-11-06 |
F. Hoffmann-La Roche Ag |
Pyrrolo[2,3-d]pyrimidine derivatives as cb2 receptor agonists
|
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
|
EP3030663B1
(en)
|
2013-07-19 |
2019-09-04 |
Monsanto Technology LLC |
Compositions and methods for controlling leptinotarsa
|
|
AU2014341879B2
(en)
|
2013-11-04 |
2020-07-23 |
Greenlight Biosciences, Inc. |
Compositions and methods for controlling arthropod parasite and pest infestations
|
|
UA119253C2
(uk)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Спосіб боротьби із вірусом у кліща varroa та у бджіл
|
|
WO2015108982A2
(en)
|
2014-01-15 |
2015-07-23 |
Monsanto Technology Llc |
Methods and compositions for weed control using epsps polynucleotides
|
|
WO2015135843A1
(de)
*
|
2014-03-10 |
2015-09-17 |
Bayer Cropscience Ag |
Heterocylische verbindungen als schädlingsbekämpfungsmittel
|
|
WO2015153339A2
(en)
|
2014-04-01 |
2015-10-08 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
|
CN106795515B
(zh)
|
2014-06-23 |
2021-06-08 |
孟山都技术公司 |
用于经由rna干扰调控基因表达的组合物和方法
|
|
US11807857B2
(en)
|
2014-06-25 |
2023-11-07 |
Monsanto Technology Llc |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
|
CN106604993A
(zh)
|
2014-07-29 |
2017-04-26 |
孟山都技术公司 |
用于控制昆虫害虫的组合物和方法
|
|
MX386419B
(es)
|
2015-01-06 |
2025-03-18 |
Arena Pharm Inc |
Metodos de condiciones de tratamiento relacionadas con el receptor s1p1.
|
|
CN108064288B
(zh)
|
2015-01-22 |
2021-11-26 |
孟山都技术公司 |
用于控制叶甲属的组合物和方法
|
|
EP3302053B1
(en)
|
2015-06-02 |
2021-03-17 |
Monsanto Technology LLC |
Compositions and methods for delivery of a polynucleotide into a plant
|
|
WO2016196782A1
(en)
|
2015-06-03 |
2016-12-08 |
Monsanto Technology Llc |
Methods and compositions for introducing nucleic acids into plants
|
|
EP3939965A1
(en)
|
2015-06-22 |
2022-01-19 |
Arena Pharmaceuticals, Inc. |
Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in sipi receptor-associated disorders
|
|
MA47504A
(fr)
|
2017-02-16 |
2019-12-25 |
Arena Pharm Inc |
Composés et méthodes de traitement de l'angiocholite biliaire primitive
|
|
ES2987794T3
(es)
|
2018-06-06 |
2024-11-18 |
Arena Pharm Inc |
Procedimientos de tratamiento de afecciones relacionadas con el receptor S1P1
|
|
CN110317204B
(zh)
*
|
2019-08-02 |
2022-02-08 |
安徽农业大学 |
吡唑并嘧啶酮类衍生物及其制备方法和应用
|